Human Growth Factors
CET engineered yeast platform secretes complex proteins with human post-translational modifications and complete folding for optimized bioactivity and stability.
CET engineered yeast platform secretes complex proteins with human post-translational modifications and complete folding for optimized bioactivity and stability.
CET engineered yeast platform secretes complex proteins with human post-translational modifications and complete folding for optimized bioactivity and stability. Their platform is efficient, simple, and engineered with users in mind. With ZERO dependency on animal origin inputs and ZERO endotoxin, CET yeast platform is the cleanest approach to protein production.
CET proprietary expression platforms produce human recombinant growth factor proteins to produce best-in-class biologics with fully native post-translational modification (PTM) and glycosylation profiles. Unlike proteins expressed from non-human E. coli and CHO-based systems, which are truncated to eliminate the glycosylated peptide sequence, their proteins reflect complete PTM profiles and glycosylation moieties that closely resemble proteins produced in vivo.
These high-quality, cost-effective growth factors are designed to promote optimal cell differentiation while lowering overall workflow costs. Discover the performance benefits of growth factor proteins with human PTMs, correct folding structure, and optimal stability.
Post-translational modifications (PTMs) and chaperoned protein folding for proper 3D structure and better stability.
Increased target cell receptivity and folding induction.
Simple and scalable manufacturing process that does not require animal-origin supplementation.
Yeast cells, unlike bacterial expression systems, feature ZERO endotoxin or inclusion bodies and naturally secrete target proteins for simpler downstream processing.
Explore CET’s product range for growth factors below: